Global Ocular Inflammation Treatment Market Size, Status and Forecast 2018-2025

Date: Sep 20 2018
|
QYRESEARCH
|
Number of Pages: 93
|
Alternate Text Alternate Text Alternate Text Alternate Text

This report focuses on the global Ocular Inflammation Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ocular Inflammation Treatment development in United States, Europe and China.

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
In 2017, the global Ocular Inflammation Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.
pSivida Corporation

Market segment by Type, the product can be split into
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal

Market segment by Application, split into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Ocular Inflammation Treatment status, future forecast, growth opportunity, key market and key players.
To present the Ocular Inflammation Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Ocular Inflammation Treatment are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
           1.4.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type (2013-2025)
           1.4.2 Immunosuppressant
           1.4.3 Monoclonal Antibodies
           1.4.4 Corticosteroids
           1.4.5 Cycloplegic Agents
           1.4.6 Antibiotics
           1.4.7 Analgesics
           1.4.8 Antivirals
           1.4.9 Antifungal
    1.5 Market by Application
           1.5.1 Global Ocular Inflammation Treatment Market Share by Application (2013-2025)
           1.5.2 Retail Pharmacies
           1.5.3 Hospital Pharmacies
           1.5.4 Online Pharmacies
           1.5.5 Drug Stores
    1.6 Study Objectives
    1.7 Years Considered
2 Global Growth Trends
    2.1 Ocular Inflammation Treatment Market Size
    2.2 Ocular Inflammation Treatment Growth Trends by Regions
           2.2.1 Ocular Inflammation Treatment Market Size by Regions (2013-2025)
           2.2.2 Ocular Inflammation Treatment Market Share by Regions (2013-2018)
    2.3 Industry Trends
           2.3.1 Market Top Trends
           2.3.2 Market Drivers
           2.3.3 Market Opportunities
3 Market Share by Key Players
    3.1 Ocular Inflammation Treatment Market Size by Manufacturers
           3.1.1 Global Ocular Inflammation Treatment Revenue by Manufacturers (2013-2018)
           3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Manufacturers (2013-2018)
           3.1.3 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
    3.2 Ocular Inflammation Treatment Key Players Head office and Area Served
    3.3 Key Players Ocular Inflammation Treatment Product/Solution/Service
    3.4 Date of Enter into Ocular Inflammation Treatment Market
    3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
    4.1 Global Ocular Inflammation Treatment Market Size by Type (2013-2018)
    4.2 Global Ocular Inflammation Treatment Market Size by Application (2013-2018)
5 United States
    5.1 United States Ocular Inflammation Treatment Market Size (2013-2018)
    5.2 Ocular Inflammation Treatment Key Players in United States
    5.3 United States Ocular Inflammation Treatment Market Size by Type
    5.4 United States Ocular Inflammation Treatment Market Size by Application
6 Europe
    6.1 Europe Ocular Inflammation Treatment Market Size (2013-2018)
    6.2 Ocular Inflammation Treatment Key Players in Europe
    6.3 Europe Ocular Inflammation Treatment Market Size by Type
    6.4 Europe Ocular Inflammation Treatment Market Size by Application
7 China
    7.1 China Ocular Inflammation Treatment Market Size (2013-2018)
    7.2 Ocular Inflammation Treatment Key Players in China
    7.3 China Ocular Inflammation Treatment Market Size by Type
    7.4 China Ocular Inflammation Treatment Market Size by Application
8 Japan
    8.1 Japan Ocular Inflammation Treatment Market Size (2013-2018)
    8.2 Ocular Inflammation Treatment Key Players in Japan
    8.3 Japan Ocular Inflammation Treatment Market Size by Type
    8.4 Japan Ocular Inflammation Treatment Market Size by Application
9 Southeast Asia
    9.1 Southeast Asia Ocular Inflammation Treatment Market Size (2013-2018)
    9.2 Ocular Inflammation Treatment Key Players in Southeast Asia
    9.3 Southeast Asia Ocular Inflammation Treatment Market Size by Type
    9.4 Southeast Asia Ocular Inflammation Treatment Market Size by Application
10 India
    10.1 India Ocular Inflammation Treatment Market Size (2013-2018)
    10.2 Ocular Inflammation Treatment Key Players in India
    10.3 India Ocular Inflammation Treatment Market Size by Type
    10.4 India Ocular Inflammation Treatment Market Size by Application
11 Central & South America
    11.1 Central & South America Ocular Inflammation Treatment Market Size (2013-2018)
    11.2 Ocular Inflammation Treatment Key Players in Central & South America
    11.3 Central & South America Ocular Inflammation Treatment Market Size by Type
    11.4 Central & South America Ocular Inflammation Treatment Market Size by Application
12 International Players Profiles
    12.1 Allergan Plc.
           12.1.1 Allergan Plc. Company Details
           12.1.2 Company Description and Business Overview
           12.1.3 Ocular Inflammation Treatment Introduction
           12.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.1.5 Allergan Plc. Recent Development
    12.2 Cipla Ltd.
           12.2.1 Cipla Ltd. Company Details
           12.2.2 Company Description and Business Overview
           12.2.3 Ocular Inflammation Treatment Introduction
           12.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.2.5 Cipla Ltd. Recent Development
    12.3 Pfizer, Inc.
           12.3.1 Pfizer, Inc. Company Details
           12.3.2 Company Description and Business Overview
           12.3.3 Ocular Inflammation Treatment Introduction
           12.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.3.5 Pfizer, Inc. Recent Development
    12.4 Novartis AG
           12.4.1 Novartis AG Company Details
           12.4.2 Company Description and Business Overview
           12.4.3 Ocular Inflammation Treatment Introduction
           12.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.4.5 Novartis AG Recent Development
    12.5 Valeant Pharmaceuticals International, Inc.
           12.5.1 Valeant Pharmaceuticals International, Inc. Company Details
           12.5.2 Company Description and Business Overview
           12.5.3 Ocular Inflammation Treatment Introduction
           12.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
    12.6 Alimera Sciences, Inc.
           12.6.1 Alimera Sciences, Inc. Company Details
           12.6.2 Company Description and Business Overview
           12.6.3 Ocular Inflammation Treatment Introduction
           12.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.6.5 Alimera Sciences, Inc. Recent Development
    12.7 Akorn, Inc.
           12.7.1 Akorn, Inc. Company Details
           12.7.2 Company Description and Business Overview
           12.7.3 Ocular Inflammation Treatment Introduction
           12.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.7.5 Akorn, Inc. Recent Development
    12.8 Abbvie, Inc.
           12.8.1 Abbvie, Inc. Company Details
           12.8.2 Company Description and Business Overview
           12.8.3 Ocular Inflammation Treatment Introduction
           12.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.8.5 Abbvie, Inc. Recent Development
    12.9 Eyegate Pharmaceuticals, Inc.
           12.9.1 Eyegate Pharmaceuticals, Inc. Company Details
           12.9.2 Company Description and Business Overview
           12.9.3 Ocular Inflammation Treatment Introduction
           12.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
    12.10 pSivida Corporation
           12.10.1 pSivida Corporation Company Details
           12.10.2 Company Description and Business Overview
           12.10.3 Ocular Inflammation Treatment Introduction
           12.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2013-2018)
           12.10.5 pSivida Corporation Recent Development
13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
    15.1 Research Methodology
           15.1.1 Methodology/Research Approach
                 15.1.1.1 Research Programs/Design
                 15.1.1.2 Market Size Estimation
                 12.1.1.3 Market Breakdown and Data Triangulation
           15.1.2 Data Source
                 15.1.2.1 Secondary Sources
                 15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details

List of Tables and Figures
Table Ocular Inflammation Treatment Key Market Segments
Table Key Players Ocular Inflammation Treatment Covered
Table Global Ocular Inflammation Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Ocular Inflammation Treatment Market Size Market Share by Type 2013-2025
Figure Immunosuppressant Figures
Table Key Players of Immunosuppressant
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Cycloplegic Agents Figures
Table Key Players of Cycloplegic Agents
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Analgesics Figures
Table Key Players of Analgesics
Figure Antivirals Figures
Table Key Players of Antivirals
Figure Antifungal Figures
Table Key Players of Antifungal
Table Global Ocular Inflammation Treatment Market Size Growth by Application 2013-2025 (Million US$)
Figure Retail Pharmacies Case Studies
Figure Hospital Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Ocular Inflammation Treatment Report Years Considered
Table Global Ocular Inflammation Treatment Market Size 2013-2025 (Million US$)
Figure Global Ocular Inflammation Treatment Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Ocular Inflammation Treatment Market Size by Regions 2013-2025 (Million US$)
Table Global Ocular Inflammation Treatment Market Size by Regions 2013-2018 (Million US$)
Table Global Ocular Inflammation Treatment Market Share by Regions 2013-2018
Figure Global Ocular Inflammation Treatment Market Share by Regions 2013-2018
Figure Global Ocular Inflammation Treatment Market Share by Regions 2018
Table Market Top Trends
Table Global Ocular Inflammation Treatment Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Ocular Inflammation Treatment Market Share by Manufacturers (2013-2018)
Figure Global Ocular Inflammation Treatment Market Share by Manufacturers in 2018
Table Global Ocular Inflammation Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ocular Inflammation Treatment Product/Solution/Service
Table Date of Enter into Ocular Inflammation Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table Global Ocular Inflammation Treatment Market Size Share by Type (2013-2018)
Figure Global Ocular Inflammation Treatment Market Size Market Share by Type (2013-2018)
Table Global Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table Global Ocular Inflammation Treatment Market Size Share by Application (2013-2018)
Figure Global Ocular Inflammation Treatment Market Size Market Share by Application (2013-2018)
Figure Global Ocular Inflammation Treatment Revenue Market Share by Application in 2017
Figure United States Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table United States Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table United States Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table United States Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table United States Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table United States Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table United States Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure Europe Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table Europe Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table Europe Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table Europe Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table Europe Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table Europe Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table Europe Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure China Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table China Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table China Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table China Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table China Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table China Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table China Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure Japan Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table Japan Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table Japan Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table Japan Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table Japan Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table Japan Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table Japan Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure Southeast Asia Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table Southeast Asia Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table Southeast Asia Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure India Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table India Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table India Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table India Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table India Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table India Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table India Ocular Inflammation Treatment Market Share by Application (2013-2018)
Figure Central & South America Ocular Inflammation Treatment Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Ocular Inflammation Treatment Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Ocular Inflammation Treatment Market Share (2017-2018)
Table Central & South America Ocular Inflammation Treatment Market Size by Type (2013-2018) (Million US$)
Table Central & South America Ocular Inflammation Treatment Market Share by Type (2013-2018)
Table Central & South America Ocular Inflammation Treatment Market Size by Application (2013-2018) (Million US$)
Table Central & South America Ocular Inflammation Treatment Market Share by Application (2013-2018)
Table Allergan Plc. Company Details
Table Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2013-2018) (Million US$)
Figure Allergan Plc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Allergan Plc. Recent Development
Table Cipla Ltd. Company Details
Table Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Cipla Ltd. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Cipla Ltd. Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Pfizer, Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Novartis AG Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Novartis AG Recent Development
Table Valeant Pharmaceuticals International, Inc. Company Details
Table Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Valeant Pharmaceuticals International, Inc. Recent Development
Table Alimera Sciences, Inc. Company Details
Table Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Alimera Sciences, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Alimera Sciences, Inc. Recent Development
Table Akorn, Inc. Company Details
Table Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Akorn, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Akorn, Inc. Recent Development
Table Abbvie, Inc. Company Details
Table Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Abbvie, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Abbvie, Inc. Recent Development
Table Eyegate Pharmaceuticals, Inc. Company Details
Table Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure Eyegate Pharmaceuticals, Inc. Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table Eyegate Pharmaceuticals, Inc. Recent Development
Table pSivida Corporation Company Details
Table pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2013-2018)(Million US$)
Figure pSivida Corporation Revenue Growth Rate in Ocular Inflammation Treatment Business (2013-2018)
Table pSivida Corporation Recent Development
Table Global Ocular Inflammation Treatment Market Size by Regions (Million US$) 2018-2025
Figure Global Ocular Inflammation Treatment Market Size Share by Regions (2018-2025)
Figure Global Ocular Inflammation Treatment Market Size Share by Regions in 2025
Figure United States Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Europe Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure China Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Japan Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure India Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Ocular Inflammation Treatment Market Size Forecast (2018-2025)(Million USD)
Table Global Ocular Inflammation Treatment Market Size by Product (2018-2025) (Million US$)
Figure Global Ocular Inflammation Treatment Market Size by Product (2018-2025)
Figure Global Ocular Inflammation Treatment Market Size by Product in 2025
Table Global Ocular Inflammation Treatment Market Size by Application (2018-2025) (Million US$)
Figure Global Ocular Inflammation Treatment Market Size by Application (2018-2025)
Figure Global Ocular Inflammation Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Electronic files(PDF) of market research reports will be dispatched within 12 to 24 hours. (Mon-Fri IST)

Select License Type

Need Help?
+
SUBSCRIBE TO THE MAILING TO KEEP UP WITH LATEST NEWS AND UPDATES
x
We use cookies to deliver the best possible experience on our website by improving the user experience, personalizing your visit, and compiling aggregate statistics. By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more visit our Privacy policy page.